Population
Carbonic anhydrase (CA) isozymes I, II, and IV
Design
Preclinical
Authors
Loading...
These derivatives may guide selective CA I inhibitor development; leaves open any cardiovascular applications pending human studies.
The newly synthesized ureido and thioureido derivatives of aromatic sulfonamides may serve as lead molecules for developing more selective CA I inhibitors.
Scozzafava et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: